Price Band
₹100 - ₹105
Lot Size
1200
Issue Size
₹25.77 Cr
GMP
N/A
Subscription
6.83x
Analyzing...
IPO Schedule
1
Open
31 Jul 2025
2
Close
4 Aug 2025
3
Allotment
-
4
Listing
7 Aug 2025
About Renol Polychem
Renol Polychem manufactures and exports polymer compounds, catering to diverse industries. Their product portfolio includes a wide range of thermoplastic elastomers and engineering plastics. They are an SME focusing on specialized polymer solutions.
Key Strengths
- High Return on Equity (ROE) of 45.37% indicates strong profitability and efficient use of shareholder funds.
- Relatively low P/E ratio of 11.54 suggests the IPO is reasonably priced compared to earnings.
- Established presence in the polymer compounds market with export capabilities.
- Diversified product portfolio catering to various industries reduces dependence on a single sector.
- Focus on specialized polymer solutions allows for higher margins and differentiation.
Risk Factors
- •SME IPOs generally carry higher risk compared to mainboard IPOs due to smaller company size and potential liquidity issues.
- •The polymer industry is subject to fluctuations in raw material prices, which can impact profitability.
- •Competition from larger, more established players in the polymer compound market.
Valuation Analysis
The IPO appears reasonably valued based on its low P/E ratio and strong ROE, suggesting potential upside; however, investors should carefully consider the inherent risks associated with SME IPOs and the polymer industry.
IPO Details
ExchangeNSE
SegmentSME
ISININE0VZX01015
NSE SymbolRNPL
Face Value₹10
Lot Size1200
Issue Size₹25.77 Cr
Key Metrics
ROE45.37%
ROCE64.18%
P/E Ratio11.54
Industry P/E20
EPS9.10
PAT Margin8.02%
Debt/Equity0.52
Growth & Quality
ProfitableYes ✓
Subscription
Total1.11x
Documents
RHP not available
Key Dates
Open Date31 Jul 2025
Close Date4 Aug 2025
Listing7 Aug 2025